Lista de obras - Elísabeth Pérez Ruiz - Dominio Público Uruguay

Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma.

artículo científico publicado en 2017

Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy

artículo científico publicado en 2017

Anti-angiogenic treatment (sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature ⬇️

artículo científico publicado en 2011

Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.

artículo científico publicado en 2017

Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice

artículo científico publicado en 2009

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

artículo científico publicado en 2018

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy

artículo científico publicado en 2018

Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.

artículo científico publicado en 2010

Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study

scientific article published on 04 January 2019

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

article

Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer.

artículo científico publicado en 2015

Cross-cultural adaptation, reliability and validity of the Spanish version of the Quality of Life in Adult Cancer Survivors (QLACS) questionnaire: application in a sample of short-term survivors

artículo científico publicado en 2015

Current status of anti-angiogenic agents in the treatment of ovarian carcinoma.

artículo científico publicado en 2009

Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

artículo científico publicado en 2019

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

artículo científico publicado en 2017

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.

artículo científico publicado en 2017

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

artículo científico publicado en 2016

Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.

artículo científico publicado en 2016

Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer

artículo científico publicado en 2017

First hospital contact via the Emergency Department is an independent predictor of overall survival and disease-free survival in patients with colorectal cancer

artículo científico publicado en 2019

Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population.

artículo científico publicado en 2019

Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?

artículo científico publicado en 2012

High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.

artículo científico publicado en 2018

Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation.

artículo científico publicado en 2012

Immunological Landscape and Clinical Management of Rectal Cancer

artículo científico publicado en 2016

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

artículo científico publicado en 2018

Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy

scientific article published on 01 August 2011

Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice

artículo científico publicado en 2020

Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity

scientific article published on 27 June 2019

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

artículo científico publicado en 2018

International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain

scientific article published on 04 September 2018

Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients.

artículo científico publicado en 2012

Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status ⬇️

artículo científico publicado el 1 de junio de 2011

Maintenance treatment in metastatic breast cancer.

artículo científico publicado en 2008

New cutaneous toxicities with generic docetaxel: are the excipients guilty?

article

Outcome of Small Invasive Breast Cancer with No Axillary Lymph Node Involvement

scientific article published on 06 December 2010

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.

artículo científico publicado en 2017

Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature

artículo científico publicado en 2013

Prognosis of Microinvasive Breast Carcinoma with Negative Axillary Nodes in Accordance with TNM Classification Criteria

artículo científico publicado en 2010

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

scientific article published on 01 May 2019

Response to paclitaxel in a radiotherapy-induced breast angiosarcoma

article

SEOM clinical guidelines to primary prevention of cancer (2018)

scientific article published on 03 January 2019

Second complete remission induced by cyclophosphamide plus bevacizumab in two patients with heavily pre-treated ovarian cancer

artículo científico publicado en 2009

Targeted therapy of metastatic breast cancer.

artículo científico publicado en 2009

The role and prognostic value of apoptosis in colorectal carcinoma

artículo científico publicado en 2013

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer

scientific article published on 18 June 2020

Lista de obras de Elísabeth Pérez Ruiz

Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma.

Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy

Anti-angiogenic treatment (sunitinib) for disseminated malignant haemangiopericytoma: a case study and review of the literature ⬇️

Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.

Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy

Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.

Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer.

Cross-cultural adaptation, reliability and validity of the Spanish version of the Quality of Life in Adult Cancer Survivors (QLACS) questionnaire: application in a sample of short-term survivors

Current status of anti-angiogenic agents in the treatment of ovarian carcinoma.

Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15.

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location

Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population.

Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer

First hospital contact via the Emergency Department is an independent predictor of overall survival and disease-free survival in patients with colorectal cancer

Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population.

Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?

High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer.

Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation.

Immunological Landscape and Clinical Management of Rectal Cancer

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Impact of Epidermal Growth Factor Receptor Expression on Disease-Free Survival and Rate of Pelvic Relapse in Patients With Advanced Cancer of the Cervix Treated With Chemoradiotherapy

Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice

Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

International Symposium: Trailblazing in Cancer Immunotherapy, October 29-31, 2017, Pamplona, Spain

Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients.

Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status ⬇️

Maintenance treatment in metastatic breast cancer.

New cutaneous toxicities with generic docetaxel: are the excipients guilty?

Outcome of Small Invasive Breast Cancer with No Axillary Lymph Node Involvement

Pembrolizumab for advanced melanoma: experience from the Spanish Expanded Access Program.

Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature

Prognosis of Microinvasive Breast Carcinoma with Negative Axillary Nodes in Accordance with TNM Classification Criteria

Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

Response to paclitaxel in a radiotherapy-induced breast angiosarcoma

SEOM clinical guidelines to primary prevention of cancer (2018)

Second complete remission induced by cyclophosphamide plus bevacizumab in two patients with heavily pre-treated ovarian cancer

Targeted therapy of metastatic breast cancer.

The role and prognostic value of apoptosis in colorectal carcinoma

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer